| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |